2638 Effectiveness of 2nd-line and subsequent therapies...

2638 Effectiveness of 2nd-line and subsequent therapies after pazopanib (Paz) in patients (pt) with metastatic renal cell carcinoma (mRCC): Final results of the SPAZO study (SOGUG)

Arija, J.A. Arranz, Pérez-Valderrama, B., González-Larriba, J.L., Rodríguez Sánchez, A., Chirivella, I., Pinto, A., Marrero, R.D. García, Rubio, G., García, J.M. Jurado, Borrega, P., Quintela, M. Láza
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31455-1
Date:
September, 2015
File:
PDF, 63 KB
english, 2015
Conversion to is in progress
Conversion to is failed